market access

Market Access

Blue and white pills in pharma manufacturing line

Pharma’s most expensive question is the last one asked

Whether a drug can secure reimbursement is pharma's billion-dollar question, and the companies that succeed will be those that answer it sooner.

News

Jen Norton appointed market access leader at EVERSANA

EVERSANA has named Jen Norton as president of its recently formed Market Access & Value division.

R&D

startup discussion investment ideas visual

Strategies for creating an ecosystem to support early-stage ...

Learn how to foster growth for early-stage biotech companies through innovative ecosystem strategies and valuable CDMO collaborations

Market Access

The stealth market access strategy that’s quietly making man...

There is an under-the-radar market access strategy that some manufacturers have implemented, but many others remain unaware of.

Market Access

Partner Content

The Inaugural Market Access for CNS Therapeutics Summit Has ...

The only dedicated forum focused on tackling the unique commercial and reimbursement challenges facing treatments for neurodegeneration...

Market Access

Looking ahead in 2025 and MHRA reliance

International reliance is a mechanism whereby certain medical devices could access the UK market more quickly if they have already been approved by a comparable regulator, rather than under

Pharma’s most expensive question is the last one asked

Jen Norton appointed market access leader at EVERSANA

Strategies for creating an ecosystem to support early-stage ...

The stealth market access strategy that’s quietly making man...

The Inaugural Market Access for CNS Therapeutics Summit Has ...

Looking ahead in 2025 and MHRA reliance

Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer

Discover a new era of healthcare panel engagement: Grounded ...

market access

Editor's Picks